NC
PIIIW icon

Nehal Chopra’s P3 Health Partners Inc Warrant PIIIW Stock Holding History

Nehal Chopra’s Portfolio PIIIW Stock Details PIIIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-32,968
Closed -$29K – 93
2021
Q3 		$29K Buy
+32,968
New +$39.5K ﹤0.01% 139

Other funds holding PIIIW

LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
AC
Athos Capital Hong Kong $282M AUM 11.4% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
KC
Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return
CF
Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return

Nehal Chopra's PIIIW Position: Q4 2021 in Review

Nehal Chopra sold out of P3 Health Partners Inc Warrant (PIIIW) in Q4 2021, closing a stake of 32,968 shares — an estimated $29K sold.

Nehal Chopra first reported a position in PIIIW in Q3 2021 and held it in 1 quarter. The position peaked at $29K in Q3 2021. 40 funds tracked by Wall St. Rank hold PIIIW as of Q4 2021.

  • Nehal Chopra reported no remaining P3 Health Partners Inc Warrant position as of Q4 2021 after selling out during the quarter.
  • Nehal Chopra sold 32,968 P3 Health Partners Inc Warrant shares in Q4 2021, an estimated $29K.
  • Nehal Chopra first reported a position in P3 Health Partners Inc Warrant in Q3 2021 and held it in 1 quarter.
  • Nehal Chopra's P3 Health Partners Inc Warrant position peaked at $29K in Q3 2021.
  • 40 funds tracked by Wall St. Rank held P3 Health Partners Inc Warrant as of Q4 2021.

Based on Ratan Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.